ORIGINAL ARTICLE

The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast

Zsolt Hodi, Jayeta Chakrabarti, Andrew H S Lee, John E Ronan, Christopher W Elston, Kwok Leung Cheung, John F R Robertson and Ian O Ellis

Departments of Histopathology and Surgery, Nottingham City Hospital, UK

Correspondence to:
Correspondence to:
A H S Lee
Department of Histopathology, Nottingham City Hospital, Nottingham NG5 1PB, UK;alee1{at}ncht.trent.nhs.uk

Aim: To assess the reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast. Previous studies have mostly been small, with a range of agreement from 62% to 100%.

Methods: Retrospective audit of 338 tumours surgically excised within 60 days of core biopsy, that had had oestrogen receptor assessed on both the core biopsy and tumour specimens. Surgical specimens were incised when fresh to ensure good fixation. External controls including a weakly positive tumour were included in each immunohistochemistry run.

Results: Oestrogen receptor expression was bimodal, with H score in both specimens of either 0 or >50 in 96% of tumours. Using H score cut-off of 10 for positivity, there was an agreement between core and excision in 334 of 338 tumours (98.8%). All discrepancies were between weakly positive and negative tumours. Intratumoral heterogeneity could explain the one tumour that was negative on core and positive on excision. H score tended to be slightly higher on core than excision (means 146 and 136). Better fixation on the core is the most likely explanation for this and for the three tumours that were positive on core and negative on excision. Repeat staining on tumours with discrepant results gave similar results in all except one case. An internal control was present in 97% of excisions and 55% of cores of oestrogen receptor-negative tumours; the internal control stained positively in all except two sections.

Conclusion: Oestrogen receptor can be assessed reliably on needle core biopsies of invasive carcinomas of the breast.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Arnedos, M., Nerurkar, A., Osin, P., A'Hern, R., Smith, I. E., Dowsett, M. (2009). Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC). Ann Oncol 0: mdp234v1-mdp234 [Abstract] [Full Text]  
• Walker, R A (2008). Immunohistochemical markers as predictive tools for breast cancer. J. Clin. Pathol. 61: 689-696 [Abstract] [Full Text]  
• Lee, A H S, Hodi, Z, Ellis, I O (2008). False-negative assessment of oestrogen receptor on needle core biopsy of invasive carcinoma of the breast. J. Clin. Pathol. 61: 239-240 [Full Text]  
• Rakha, E A, Ellis, I O (2007). An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens. J. Clin. Pathol. 60: 1300-1306 [Abstract] [Full Text]